Abstracts and Presentations

Alpha-defensin in synovial fluid as a new biomarker for the diagnosis of periprosthetic joint infection

AACC Clinical Lab Expo - July 2013

Alpha-defensin: A novel synovial fluid biomarker that outperforms leukocyte esterase when diagnosing periprosthetic joint infection (PJI)

The Knee Society Closed meeting- September 19-21, 2013

Diagnosing periprosthetic joint infection: The era of the biomarker has arrived

Infectious Diseases Society of America (ISDA) - October 2-6th, 2013

Alpha-defensin: A novel synovial fluid biomarker that outperforms leukocyte esterase when diagnosing periprosthetic joint infection (PJI)

Diagnosing periprosthetic joint infection: The era of the biomarker has arrived

Pennsylvania Orthopaedics Society- October 10th, 2013

Alpha-defensin: A novel synovial fluid biomarker that outperforms leukocyte esterase when diagnosing periprosthetic joint infection (PJI)

Diagnosing periprosthetic joint infection: The era of the biomarker has arrived

Eastern Orthopaedics Association- October 30th, 2013

Alpha-defensin: A novel synovial fluid biomarker that outperforms leukocyte esterase when diagnosing periprosthetic joint infection (PJI)

Diagnosing periprosthetic joint infection: The era of the biomarker has arrived

American Association of Hip and Knee Surgeons - November 8th, 2013

Alpha-defensin: A novel synovial fluid biomarker that outperforms leukocyte esterase when diagnosing periprosthetic joint infection (PJI)

Diagnosing periprosthetic joint infection: The era of the biomarker has arrived

American Academy of Orthopaedic Surgeons - March 2014